Large market share for non-quality-assured malaria medicines in Africa #Investorseurope #Malaria | Humanitarian & Cultural Causes in Africa |
A new study of malaria medicine quality in eight sub-Saharan African countries has found a large and potentially growing market for non-quality-assured (QA) malaria treatments -- medicines not pre-approved by global health organizations -- as much as 20 percent of the private-sector market in Kenya, and 42 percent in the Democratic Republic of Congo.